MedPath
HSA Approval

SATO UONOME SOLUTION

SIN04987P

SATO UONOME SOLUTION

SATO UONOME SOLUTION

June 25, 1990

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

TOPICAL

Medical Information

D11AF

疣和鸡眼治疗药

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO LTD

Active Ingredients

LACTIC ACID

8.85% w/v

Lactic acid

SALICYLIC ACID

5% w/v

Salicylic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SATO UONOME SOLUTION - HSA Approval | MedPath